基因传递系统
InternationalJournalofPharmaceutics391 (2010) 260–266
ContentslistsavailableatScienceDirect
InternationalJournalof

Pharmaceutics
journalhomepage:doc.guandang.net

m
PharmaceuticalNanotechnology
Stearicacidgraftedchitosanoligosaccharidemicelleasapromisingvectorforgenedeliverysystem:Factorsaffectingthecomplexation
Yong-ZhongDua,PingLua,b,Jian-PingZhoub, ,HongYuana,Fu-QiangHua,
ab
CollegeofPharmaceuticalScience,ZhejiangUniversity,388YuhangtangRoad,Hangzhou310058,PRChina
DepartmentofPharmaceutics,ChinaPharmaceuticalUniversity,24TongjiaxiangRoad,Nanjing210009,PRChina
articleinfoabstract
Stearicacid(SA)graftedchitosanoligosaccharide(CSO-SA)withdifferentmolecularweightofchitosanoligosaccharide(CSO)andgraftratioofstearicacidweresynthesizedbycouplingreactionofSAandCSO.ThecationicpolymericmicellesofCSO-SAviaself-assembleformedandusedforgenedeliveryof shspermDNA.FactorsaffectingcomplexationandstabilityofthecomplexesofCSO-SAmicellesandDNAwereinvestigated.TheresultsindicatedthatpKaofCSO-SAwith3kDaofCSOdecreasedfrom8.16to6.02asthesubstitutiondegreeofaminogroupsofCSOinCSO-SAincreasedfrom9.79%to63.41%,whereasthemolecularweight(MW)ofCSOlessaffectedthepKa.Asforthestabilityofcomplexes,ethidiumbromideassaydatademonstratedthatthecomplexesconsistingofCSO-SAwithloweraminosubstitutiondegreeorsmallermolecularweightofCSOweremorestablethanthatwiththehigheraminosubstitutiondegreeormolecularweightofCSO.TheresultsalsopresentedthatthelowpHandionicstrengthenvironmentwereinfavorforthestabilityofcomplexes.
© 2010 Elsevier B.V. All rights reserved.
Articlehistory:
Received9November2009
Receivedinrevisedform8January2010Accepted10February2010
Available online 17 February 2010Keywords:
ChitosanoligosaccharideStearicacid
CationicmicellesGenedeliveryvectorComplexationStability
1.Introduction
Efforthadbeenmadetoevaluatethepotentialsandbene tsofsyntheticgenevector,suchasliposome,dendrimerandpoly-cation(WasunguandHoekstra,2006;Zhangetal.,2007;Kimetal.,2009),asalternativestoviralvectorforgenedelivery.Therein,polycationattractedagreatdealofattention,becauseoftheirlowimmunogenicity,cationicproperties,easetopreparationandstruc-turemodi cation.CationicpolycationcancomplexwithanionicDNAthroughelectrostaticinteractioninnormalconditionwithoutspecialtreatment,avoidingthepossibledamagetoDNA.However,polycationwasfarawayfromaperfectgenevectorsuchaslack-ingofdegradability,lowbiocompatibility,andinparticular,lowtransfectionef ciencycomparedwithviralvector.
Chitosan,anaturalcationicpolysaccharidehadshownexcelingenedelivery.Amajorityofworkhadbeendoneonchitosan(Leeetal.,1998;MacLaughlinetal.,1998;Richardsonetal.,1999)anditwasfoundthatchitosanwasakindofbiocompatible,biodegrad-able,andlowtoxicmaterialhavingcationicpotentialinphysicalcondition,andhadprimaryaminogroupsthatallowedbeingfur-thermodi ed(Kimetal.,2007).However,chitosanhadseveraldisadvantages,whichhandicappeditssuccessfulapplicationingenedelivery.Oneofthemajordisadvantageswasthelowtrans-
Correspondingauthors.Tel.:+8657188208439;fax:+8657188208439.
E-mailaddresses:jpzhoucpu@126.com(J.-P.Zhou),hufq@zju.edu.cn(F.-Q.Hu).0378-5173/$–seefrontmatter© 2010 Elsevier B.V. All rights reserved.doi:10.1016/j.ijpharm.2010.02.017
fectionef ciency.Thetransfectionef ciencyinvitrowasreportedrangingfrom0.05%to12.1%(Huangetal.,2005),muchlowerthanthatofLipofectamineTM2000(about20%).Theotherdisadvan-tagesincludedthesolubilityproblemandlackingofcellspeci city.Chemicalmodi cationofchitosanwasafeasiblewaytoover-comethosedisadvantages,makingitmoresuitableasgenevector.Thereportedchemicalmodi cationcanbeclassi edaspotentialmodi cation,hydrophilicmodi cation,hydrophobicmodi cation,pH-sensitivemodi cation,temperature-sensitivemodi cationandspecialligandmodi cation(Kimetal.,2007).Jiangetal.(2007)andKimetal.(2003)hadcon rmedtheenhancementoftrans-fectionef ciencyafterchemicalmodi cationofchitosan.Lowmolecularweightchitosanattractedgreatattentionbecauseofgoodsolubilityinphysiologicalcondition,highergenetransfection(Köping-Höggårdetal.,2004)andmoreef cientenzymaticprotec-tion(Richardsonetal.,1999).Thosephenomenonscanbeexplainedthatmolecularweightmayin uencethestabilityofcomplexes,theef ciencyofcellularuptake,orthedissociationrateofDNAfromcomplexesafterendocytosis(LiuandYao,2002).
Stearicacidgraftedchitosanoligosaccharide(CSO-SA)isakindofhydrophobicmodi cationofchitosanoligosaccharidedevelopedbyourlab(Huetal.,2006a).TheCSO-SAcouldformmicellesintheaqueousmedium,andtheCSO-SAmicellescouldberapidlyinter-nalizedintocancercells(Youetal.,2007).Besideshavingthemeritsofchitosan,suchasbiocompatibility,biodegradability,CSO-SAalsoownsthecharacterizationofgoodsolubilityindistilledwater,nar-rowsizedistribution,reducedcelltoxicityandsuitablepositive
Gene delivery system 7页 1财富值 Chitosan Nanoparticles A... 8页 1财富值 Non-viral targeted deliv... 暂无评价 4页 2.00元 #Chitosan nanoparticles ....
9页 1财富值 Enhancement of Microbubb... 8页 2财富值 Gene delivery system 7页 1财富值 Drug and Gene Delivery 暂无评价 41页 5财富值...
11页 免费 Delivery of Information 11页 免费 information system 6页 5财富值 Project Delivery System 46页 2财富值 Gene delivery system 7页 1财富值...
基因导入系统(gene delivery system)是 基因治疗的核心技术,可分为病毒载体 系统和非病毒载体系统。 42 ? ? ? 1.病毒载体系统 用于基因治疗的病毒载体应具备以下...
GDS-80 Gene Delivery System 子弹制备流程—Helios系统 DNA与金粉共沉淀 (Spermidine/CaCl2) 悬浮在酒精中, DNA/金粉流入 塑料管中 旋转使DNA/金粉均匀分布在...
In addition, we briefly illustrate gene delivery system used in miRNA therapy and obstacles at present. Key words: MiRNA; Cancer; Gene therapy Chinese ...
共 113 页第 25 页 2008-1-28 15:21:05 PM Gene Gene expression system Gene vector system Gene delivery system 共 113 页第 26 页 2008-1-28 15:...
高表面活性 → 交联或吸附性强 Drug / Gene Delivery System 药物/基因转运系统 药物 基因转运系统 纳米粒 吸附药物/质粒 吸附药物 质粒DNA 质粒 纳米粒-药物 ...
In t his article, t he structure f orm at of cat ionic liposomes w as int roduced, tw o types of liposomes mediated gene delivery system w ith ...
transfer is reviewed in this paper, the basic principle and the latest progress and the development trend of polymeric gene delivery system were discussed....
热门文档